New Zealand markets closed

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
87.74+0.12 (+0.14%)
At close: 04:00PM EST
88.13 +0.39 (+0.44%)
After hours: 07:35PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,004,800
6,004,800
5,382,400
5,232,500
4,386,300
Cost of revenue
1,379,800
1,379,800
1,080,400
1,248,900
1,080,600
Gross profit
4,625,000
4,625,000
4,302,000
3,983,600
3,305,700
Operating expenses
Research development
1,071,800
1,071,800
945,200
903,100
760,700
Selling general and administrative
1,823,400
1,823,400
1,566,500
1,494,000
1,228,400
Total operating expenses
2,895,200
2,895,200
2,511,700
2,397,100
1,989,100
Operating income or loss
1,729,800
1,729,800
1,790,300
1,586,500
1,316,600
Interest expense
17,600
17,600
19,200
18,400
15,800
Total other income/expenses net
-181,300
-181,300
-39,200
116,500
-407,500
Income before tax
1,598,100
1,598,100
1,767,400
1,702,000
916,700
Income tax expense
198,700
198,700
245,500
198,900
93,300
Income from continuing operations
1,399,400
1,399,400
1,521,900
1,503,100
823,400
Net income
1,402,400
1,402,400
1,521,900
1,503,100
823,400
Net income available to common shareholders
1,402,400
1,402,400
1,521,900
1,503,100
823,400
Basic EPS
2.35
-
2.46
2.41
1.32
Diluted EPS
2.34
-
2.44
2.38
1.30
Basic average shares
608,650
-
619,000
623,300
622,600
Diluted average shares
611,675
-
624,200
631,200
631,900